Our members had a very notable participation in the European Association for Cancer Research (EACR) 2024: Innovative Cancer Science annual congress, held in Rotterdam from 10-13. June 2024.
Ivana Pašić from the Institute of Oncology and Radiology of Serbia and Milan Beljkaš from the Faculty of Pharmacy of the UB were awarded EACR Travel grant scholarships for abstracts:
Deciphering the anticancer activity of Cotinus coggygria extracts and compounds with high selectivity against myelogenous leukemia cells
Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment
Dr. Miloš Lazarević and Dr. Dijana Mitić from the Faculty of Dentistry of the UB presented the results of the IDEJE project of the RS Science Fund: Oral cancer – new approaches in prevention, control and post operative regeneration – an in vitro study (ORCA-PCR, orca-pcrideas.com) under the direction of prof. Jelena Milasin:
orca-pcrideas.com
Effect of BET inhibitors on oral squamous cell carcinoma cell line and its CD44 positive subpopulation
Lactobacillus salivarius as an Adjuvant to Antitumor Effect of Paclitaxel on oral squamous cell carcinoma
Dr. Ana Đurić from the Institute of Oncology and Radiology of Serbia presented the results of the STEPUPIORS Horizon Europe Twinning Project:
Expanding the Landscape of Professional Project Management to Support Cancer Research in Serbia
www.stepupiors.eu
All abstracts are available online in the journal Molecular Oncology
Dr. Milena Čavić, on behalf of the Board of Directors, discussed with EACR representatives about the organization of the regional HDIR-MOKAD-SDIR congress in 2025.
Congratulations to all colleagues and we look forward to the EACR 2025 Congress in Lisbon!
